NT5C3A and inclusion body myositis: Interestingly, our group’s previous findings depicting aberrant levels of BACE1 and PSN1 proteins in the plasma of IBM patients may confirm the systemic impact of the disease and the implication of amyloidogenesis in IBM [31].